Mammographic patterns as a predictive biomarker of breast cancer risk: Effect of tamoxifen

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 10, 1999, Pages 863-866

  Atkinson, Charlotte ^a   Warren, Ruth ^b   Bingham, Sheila A ^c   Day, Nicholas E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ISOFLAVONE; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; RISK FACTORS; TAMOXIFEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0032709388     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Feig, S. A. Breast masses. Mammographic and sonographic evaluation. Radiol. Clin. North Am., 30: 67-92, 1992.
2. Wolfe, J. N. Breast patterns as an index of risk for developing breast cancer. Am. J. Roentgenol., 126: 1130-1139, 1976.
3. Byrne, C. Studying mammographic density: implications for understanding breast cancer. J. Natl. Cancer Inst., 89: 531-533, 1997.
4. Pankow, J. S., Vachon, C. M., Kuni, C. C., King, R. A., Arnett, D. K., Grabrick, D. M., Rich, S. S., Anderson, V. E., and Sellers, T. A. Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J. Natl. Cancer Inst., 89: 549-556, 1997.
5. Boyd, N. F., Greenberg, C., Lockwood, G., Little, L., Martin, L., Byng, J., Yaffe, M., and Tritchler, D. Effects at two years of a low-fat, high carbohydrate diet on radiologic features of the breast: results from a randomized trial. J. Natl. Cancer Inst., 89: 488-496, 1997.
6. Laya, M. B., Larson, E. B., Taplin, S. H., and White, E. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J. Natl. Cancer Inst., 88: 643-649, 1996.
7. Furr, B. J. A., and Jordan, V. C. The pharmacology and clinical uses of tamoxifen. Pharmacol. Ther., 25: 127-205, 1984.
8. Ursin, G., Pike, M. C., Spicer, D. V., Porrath, S. A., and Reitherman, R. W. Can mammographic densities predict effects of tamoxifen on the breast? J. Natl. Cancer Inst., 88: 128-129, 1996.
9. Day, N. E., and Duffy, S. W. Trial design based on surrogate end points-application to comparison of different breast screening frequencies. J. R. Stat. Soc. A., 159: 49-60, 1996.
10. Laya, M. B., Gallagher, J. C., Schreiman, J. S., Larson, E. B., Watson, P., and Weinstein, L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology, 196: 433-437, 1995.
11. Cyrlak, D., and Wong, C. H. Mammographic changes in postmenopausal women undergoing hormonal replacement therapy. Am. J. Roentgenol., 161: 1171-1183, 1993.
12. Stomper, P. C., Van Voorhis, B. J., Ravnikar, V. A., and Meyer, J. E. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology, 174: 487-490, 1990.
13. Berkowitz, J. E., Gatewood, O. M. B., Goldblum, L. E., and Gayler, B. W. Hormonal replacement therapy: mammographic manifestations. Radiology, 174: 199-201, 1990.
14. Verbeek, A. L. M., Hendriks, J. H. C. L., Peeters, P. H. M., and Sturmans, F. Mammographic breast pattern and the risk of breast cancer. Lancet, 1: 591-593, 1984.
15. Wolfe, J. N., Saftlas, A. F., and Salane, M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. Am. J. Roentgenol., 148: 1087-1092, 1987.
16. Spicer, D. V., Ursin, G., Parisky, Y. R., Pearce, J. G., Shoupe, D., Pike, A., and Pike, M. C. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J. Natl. Cancer Inst., 86: 431-436, 1994.
17. Kaufman, Z., Garstin, W. I. H., Hayes, R., Michell, M. J., and Baum, M. The mammographic parenchymal patterns of women on hormonal replacement therapy. Clin. Radiol., 43: 389-392, 1991.
18. Demark-Wahnefried, W., Rimer, B. K., and Winer, E. P. Weight gain in women diagnosed with breast cancer. J. Am. Diet. Assoc., 97: 519-526, 1997.
19. Boyd, N. F., Lockwood, G. A., Byng, J. W., Tritchler, D. L., and Yaffe, M. J. Mammographic densities and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 7: 1133-1144, 1998.
20. Goodwin, P. J., Ennis, M., Pritchard, K. I., McCready, D., Koo, J., Sidlofsky, S., Trudeau, M., Hood, N., and Redwood, S. Adjuvant treatment and onset of menopause predict weight gain after breats cancer diagnosis. J. Clin. Oncol. 77: 120-129, 1999.
21. Nayfield, S. G., Karp, J. E., Ford. L. G., Dorr, F. A., and Kramer, B. S. Potential role of tamoxifen in prevention of breast cancer. J. Natl. Cancer Inst., 83: 1450-1459, 1991.
22. CRC Adjuvant Breast Trial Working Party. Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. Br. J. Cancer. 57: 604-607, 1988.
23. Threatt, B., Norbeck, J. M., Ullman, N. S., Kummer, R., and Roselle, P. Association between mammographic parenchymal pattern classification and risk of breast cancer. Cancer (Phila.). 45: 2550-2556, 1980.
24. Day, N. E. Screening for breast cancer. Br. Med. Bull., 47: 400-415, 1991.
25. Cassidy, A., Bingham, S., and Setchell, K. D. R. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am. J. Clin. Nutr., 60: 333-340, 1994.